Methods: In the initial phase of the clinical pharmacology study, 12 women received a single oral dose of anastrozole 0.5 or 1mg. Then, a further 12 women received anastrozole 0.5 or 1 mg/day for ...

Nearly 300,000 women in England will be offered a preventative pill to help them avoid breast cancer. The drug, anastrozole, has been available for years as a breast cancer treatment, and had ...

Patients were randomly allocated to receive anastrozole 1 mg daily or placebo, in addition to their usual GH therapy, and were examined at 3-month intervals. Anastrozole treatment continued for 36 ...

Anastrozole is a non-steroidal inhibitor used with other treatments, such as surgery or radiation, to treat early breast cancer in women who have experienced menopause.

The treatment is taken as a 1mg tablet, once a day for five years. Anastrozole works by cutting down the amount of the hormone oestrogen that a patient’s body makes by blocking an enzyme called ...

Participants were randomly assigned to receive either anastrozole 1 mg daily or placebo for 12 months; 11 men from the anastrozole group and 8 from the placebo withdrew from the study. Changes in ...

This study reveals that Fe-doped boron nitride nanoparticles improve Anastrozole delivery, offering enhanced stability and targeted therapy for breast cancer.

First, 12 randomly selected participants were randomly divided into two groups each comprising six members and assigned to receive a single oral dose of anastrozole 0.5 or 1mg after a fast of 10 ...